| Tuesday January 31, 2006 |
| 7:30-8:15 AM
|
Registration & Continental Breakfast |
| 8:15 |
Welcoming Remarks |
Scott Keefer, Sr.
Applications Scientist Cellomics' Center of
Excellence |
| 8:25-8:45 |
Cellomics Update |
Dan Calvo,
President &
CEO, Cellomics |
| 8:45-9:30 |
Cellomics Product Update for 2006
|
Joe Zock, Manager, Customer Support
Mark Collins, Ph.D., Sr. Product Manager, BioInformatics
Sarah Tencza, Ph.D., Product Manager, BioApplications |
| 9:30-10:00 |
“Identifying and quantifying phenotypic changes with High Content Screening by integrating Cellomics ArrayScan VTI HCS Reader and Dharmacon’s siRNA library” |
Anja Smith, Ph.D.
Research Scientist II
Dharmacon, Inc.
Lafayette, CO |
| 10:00-10:20 |
Biosensors and gene switched proteins for High Content Screening |
D. Lansing Taylor, Ph.D.
President and CEO
Cellumen Inc.,
Pittsburgh, PA |
| 10:20-10:35 |
Coffee Break |
| 10:35-11:00 |
Evolution of a Cytometry Laboratory: or- How I learned to Stop Worrying and Love HCS |
David Gebhard
Principal Scientist
Exploratory Medicinal Sciences/ Lead Assessment Team
Pfizer Inc. Groton CT. |
| 11:00-11:25 |
Ramping up for Quantitative Analysis of Embryonic Stem Cell Derived Cardiac Myocyte Progenitors |
Lila Collins, Ph.D.
Geron Inc.
Menlo Park, CA |
| 11:25-11:50 |
Application Moment – Live Demonstration
Neuronal Profiling |
Neil Durso, Ph.D., Manager, Field Applications |
11:50-
12:15 PM |
Open Forum – A Facilitated discussion to “Ask Cellomics” |
Panel Members:
Dan Calvo, CEO, Cellomics
Mark Collins, Sr. Product Manager, BioInformatics
Sarah Tencza, Product Manager, BioApplicaitons
Rick Salisbury, Director, Product Development
Neil Durso, Manager, Field Applicaitons |
| 12:15-1:00 |
Lunch provided by Cellomics
Open seating |
| 1:00-1:45 |
Cellomics Tips and Tricks –
6 things you need to know about. |
Joe Zock, Manager Customer Support
Neil Durso, Ph.D., Manager, Field Applications
Scott Keefer, Sr. Application Scientist, Center of Excellence |
| 1:45-2:15 |
HCS Manipulation of a Mitotic Indexing Marker for Detection of Aurora Kinase Inhibition |
Kristin Gamo
Staff Research Associate I
Sunesis Pharmaceuticals, Inc.
South San Francisco, CA |
| 2:15-2:45 |
Profiling Anti-Angiogenic Compounds Using a High Content Endothelial Cell Cord Formation Assay |
Mark Uhlik, Ph.D.,
Scientist
Eli Lilly and Company, Indianapolis IN |
| 2:45 |
Closing remarks |
Dan Calvo, CEO, Cellomics
Scott Keefer, Sr. Application Scientist, Center of Excellence. |
| 3:00 |
Adjourned |
